Showing results (1-10 of 97) with videos related to
Sort By:
Pageof 10
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1991
Antidepressant for substance-abusing schizophrenic patients: a minireviewS G Siris, P C Bermanzohn, S E Mason, et al.Archives of General Psychiatry|February 1, 1994
Maintenance imipramine therapy for secondary depression in schizophrenia. A controlled trialS G Siris, P C Bermanzohn, S E Mason, et al.Psychopharmacology Bulletin|January 1, 1992
Continuation treatment with adjunctive imipramine in schizophreniaS G Siris, P C Bermanzohn, S E Mason, et al.Psychopharmacology Bulletin|January 1, 1993
Adjunctive imipramine in substance-abusing dysphoric schizophrenic patientsS G Siris, S E Mason, P C Bermanzohn, et al.Psychopharmacology Bulletin|January 1, 1991
The use of antidepressants for negative symptoms in a subset of schizophrenic patientsS G Siris, P C Bermanzohn, A Gonzalez, et al.Psychiatry|January 27, 1999
Clinical trials and tribulations: implementation processes in schizophrenia research outcomeS E Mason, P C Bermanzohn, S G SirisProgress in Neuro-Psychopharmacology & Biological Psychiatry|July 1, 1993
Histories of substance abuse, panic and suicidal ideation in schizophrenic patients with histories of post-psychotic depressionsS G Siris, S E Mason, M A ShuwallComprehensive Psychiatry|July 1, 1992
Akinesia: a syndrome common to parkinsonism, retarded depression, and negative symptoms of schizophreniaP C Bermanzohn, S G SirisThe Journal of Clinical Psychiatry|November 1, 1994
Noncompliance with antiparkinsonian medications in neuroleptic-treated schizophrenic patients: three cases of an unreported phenomenonP C Bermanzohn, S G SirisProgress in Neuro-Psychopharmacology & Biological Psychiatry|July 1, 1992
Adjunctive imipramine for dysphoric schizophrenic patients with past histories of cannabis abuseS G Siris, P C Bermanzohn, S E Mason, et al.Pageof 10